{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:29:43Z","timestamp":1789039783392,"version":"build-2803163510"},"reference-count":143,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["Hamp1"],"award-info":[{"award-number":["Hamp1"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bbadis.2018.08.030","type":"journal-article","created":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T01:10:53Z","timestamp":1535245853000},"page":"1925-1937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Role of iron metabolism in heart failure: From iron deficiency to iron overload"],"prefix":"10.1016","volume":"1865","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Zhabyeyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.08.030_bb0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ehf2.12179","article-title":"Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany","volume":"4","author":"Theidel","year":"2017","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0010","doi-asserted-by":"crossref","first-page":"1640S","DOI":"10.3945\/ajcn.117.155978","article-title":"Iron status of toddlers, nonpregnant females, and pregnant females in the United States","volume":"106","author":"Gupta","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0015","doi-asserted-by":"crossref","first-page":"1663S","DOI":"10.3945\/ajcn.117.156018","article-title":"Iron status of young children in Europe","volume":"106","author":"van der Merwe","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0020","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","article-title":"Disorders of iron metabolism","volume":"341","author":"Andrews","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0025","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0030","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJM198805263182103","article-title":"Prevalence of hemochromatosis among 11,065 presumably healthy blood donors","volume":"318","author":"Edwards","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0035","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1016\/j.lpm.2017.10.007","article-title":"Iron overload in hematological disorders","volume":"46","author":"Fibach","year":"2017","journal-title":"Presse Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0040","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","article-title":"Beta-thalassemia","volume":"353","author":"Rund","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCHEARTFAILURE.109.913863","article-title":"Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives","volume":"3","author":"Kremastinos","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0050","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMra1404415","article-title":"The alpha-thalassemias","volume":"371","author":"Piel","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0060","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0065","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/srep18132","article-title":"Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy","volume":"5","author":"Das","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0075","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0080","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/labinvest.2017.111","article-title":"Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology","volume":"98","author":"Vela","year":"2018","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0090","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2005.06.025","article-title":"Identification of an intestinal heme transporter","volume":"122","author":"Shayeghi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cell.2006.09.041","article-title":"Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption","volume":"127","author":"Qiu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0100","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.3748\/wjg.14.4101","article-title":"Mechanisms of heme iron absorption: current questions and controversies","volume":"14","author":"West","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cell.2004.08.014","article-title":"Identification of a human heme exporter that is essential for erythropoiesis","volume":"118","author":"Quigley","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0110","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0115","doi-asserted-by":"crossref","first-page":"25866","DOI":"10.1074\/jbc.M401467200","article-title":"HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface","volume":"279","author":"Giannetti","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0120","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jhep.2012.06.015","article-title":"The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation","volume":"57","author":"D'Alessio","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0125","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1089\/ars.2011.4271","article-title":"Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action","volume":"18","author":"Lawen","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0130","first-page":"835","article-title":"Hemochromatosis protein (HFE) knockout mice as a novel model of hemochromatosis: implications for study and management of iron-overload cardiomyopathy","volume":"33","author":"Zhabyeyev","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0005-2736(81)90143-7","article-title":"Inhibition of reticulocyte iron uptake by NH4Cl and CH3NH2","volume":"642","author":"Morgan","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0167-4889(83)90069-1","article-title":"The effect of lysosomotrophic bases and inhibitors of transglutaminase on iron uptake by immature erythroid cells","volume":"762","author":"Armstrong","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0145","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ng1658","article-title":"Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells","volume":"37","author":"Ohgami","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2015.12.060","article-title":"Hemoglobin-induced neuronal degeneration in the hippocampus after neonatal intraventricular hemorrhage","volume":"1635","author":"Garton","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0155","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/jnc.13720","article-title":"Haptoglobin increases the vulnerability of CD163-expressing neurons to hemoglobin","volume":"139","author":"Chen-Roetling","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0160","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1189\/jlb.0706453","article-title":"CD163-expressing monocytes constitute an endotoxin-sensitive Hb clearance compartment within the vascular system","volume":"82","author":"Schaer","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fphys.2014.00415","article-title":"Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development","volume":"5","author":"Schaer","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0175","first-page":"373","article-title":"Unravelling the molecular basis for cardiac iron metabolism and deficiency in heart failure","volume":"38","author":"Zhabyeyev","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02829934","article-title":"A precious metal: Iron, an essential nutrient for all cells","volume":"1","author":"Cairo","year":"2006","journal-title":"Genes Nutr."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0185","doi-asserted-by":"crossref","first-page":"17791","DOI":"10.1074\/jbc.M113.460253","article-title":"Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin","volume":"288","author":"Leidgens","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0190","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.3685996","article-title":"Identification of the iron-responsive element for the translational regulation of human ferritin mRNA","volume":"238","author":"Hentze","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0195","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1126\/science.2452485","article-title":"Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation","volume":"240","author":"Casey","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0200","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0092-8674(88)90098-0","article-title":"A stem-loop in the 3\u2032 untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm","volume":"53","author":"Mullner","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0205","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nchembio807","article-title":"The role of iron regulatory proteins in mammalian iron homeostasis and disease","volume":"2","author":"Rouault","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fphar.2014.00176","article-title":"The IRP\/IRE system in vivo: insights from mouse models","volume":"5","author":"Wilkinson","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0215","doi-asserted-by":"crossref","first-page":"16529","DOI":"10.1074\/jbc.270.28.16529","article-title":"Characterization and expression of iron regulatory protein 2 (IRP2). Presence of multiple IRP2 transcripts regulated by intracellular iron levels","volume":"270","author":"Guo","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0225","first-page":"362","article-title":"Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure","volume":"38","author":"Haddad","year":"2017","journal-title":"Eur. Heart J."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2018.08.030_bb0230","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0235","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0240","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ejhf.640","article-title":"Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis","volume":"19","author":"Melenovsky","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0245","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0250","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.000345","article-title":"Oral Iron therapy for heart failure with reduced ejection fraction: design and rationale for oral Iron repletion effects on oxygen uptake in heart failure","volume":"9","author":"Lewis","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0255","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral Iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0260","author":"W.H. Organization"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0265","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.3748\/wjg.15.4627","article-title":"Classification of anemia for gastroenterologists","volume":"15","author":"Moreno Chulilla","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0270","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.107.698514","article-title":"Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia","volume":"117","author":"Ghali","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0275","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/eurheartj\/ehm328","article-title":"Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia","volume":"28","author":"van Veldhuisen","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0280","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jacc.2006.11.024","article-title":"Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial","volume":"49","author":"Ponikowski","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0285","doi-asserted-by":"crossref","unstructured":"K. Swedberg, J.B. Young, I.S. Anand, S. Cheng, A.S. Desai, R. Diaz, A.P. Maggioni, J.J. McMurray, C. O'Connor, M.A. Pfeffer, S.D. Solomon, Y. Sun, M. Tendera, D.J. van Veldhuisen, Treatment of anemia with darbepoetin alfa in systolic heart failure, N. Engl. J. Med., 368 (2013) 1210\u20131219.","DOI":"10.1056\/NEJMoa1214865"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0290","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","article-title":"Lethal cardiomyopathy in mice lacking transferrin receptor in the heart","volume":"13","author":"Xu","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0295","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2006.07.015","article-title":"Intravenous iron alone for the treatment of anemia in patients with chronic heart failure","volume":"48","author":"Bolger","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0300","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0305","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0310","first-page":"236","article-title":"Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency","volume":"21","author":"Usmanov","year":"2008","journal-title":"Journal of nephrology"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0315","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0320","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1525-139x.2000.00104.x","article-title":"s","volume":"13","author":"Fishbane","year":"2000","journal-title":"Semin. Dial."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0325","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2326-11-4","article-title":"Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data","volume":"11","author":"Moore","year":"2011","journal-title":"BMC blood disorders"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0330","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40256-016-0211-2","article-title":"Iron therapy in patients with heart failure and iron deficiency: review of iron preparations for practitioners","volume":"17","author":"Drozd","year":"2017","journal-title":"American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0335","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jacc.2011.01.059","article-title":"Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure","volume":"58","author":"Maeder","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0340","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/eurjhf\/hfr093","article-title":"CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure","volume":"13","author":"McMurray","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0345","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0350","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(00)01920-7","article-title":"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity","volume":"480","author":"Krause","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0355","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19804","article-title":"An essential cell-autonomous role for hepcidin in cardiac iron homeostasis","volume":"5","author":"Lakhal-Littleton","year":"2016","journal-title":"elife"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0360","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BJ20110225","article-title":"GATA-4 transcription factor regulates hepatic hepcidin expression","volume":"437","author":"Island","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0365","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.ijcard.2013.12.067","article-title":"Hepcidin is increased in the hypertrophied heart of dahl salt-sensitive rats","volume":"172","author":"Naito","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0370","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1745-6673-9-11","article-title":"Silencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytes","volume":"9","author":"Hsieh","year":"2014","journal-title":"J Occup Med Toxicol"},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2018.08.030_bb0375","first-page":"S28","article-title":"Oral iron supplementation: potential implications for the gut microbiome and metabolome in patients with CKD","volume":"21","author":"Kortman","year":"2017","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0380","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/gutjnl-2015-309940","article-title":"Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD","volume":"66","author":"Lee","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117383","article-title":"Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis","volume":"10","author":"Tolkien","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0390","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2015-05-642223","article-title":"Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women","volume":"126","author":"Moretti","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0395","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/10408690091189194","article-title":"Effect of tea and other dietary factors on iron absorption","volume":"40","author":"Zijp","year":"2000","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0400","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ajcn\/53.1.106","article-title":"Calcium supplementation: effect on iron absorption","volume":"53","author":"Cook","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0405","first-page":"899","article-title":"Iron deficiency anemia due to the long-term use of a proton pump inhibitor, internal medicine (Tokyo, Japan)","volume":"57","author":"Imai","year":"2018"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0410","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2010.12.016","article-title":"Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure","volume":"157","author":"Sandek","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0415","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","article-title":"Iron status in patients with chronic heart failure","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0420","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.ejcn.1602917","article-title":"Improved adherence and anaemia cure rates with flexible administration of micronutrient sprinkles: a new public health approach to anaemia control","volume":"63","author":"Ip","year":"2009","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0425","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/bloodadvances.2016000521","article-title":"The lucky iron fish: a simple solution for iron deficiency","volume":"1","author":"Armstrong","year":"2017","journal-title":"Blood advances"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0430","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69061.x","article-title":"Strategies for iron supplementation: oral versus intravenous","volume":"69","author":"MacDougall","year":"1999","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0435","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69119.x","article-title":"Toxicity of parenteral iron dextran therapy","volume":"69","author":"Burns","year":"1999","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0440","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/eurjhf\/hfp140","article-title":"Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia","volume":"11","author":"Anker","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0445","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.1978.tb03662.x","article-title":"Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity","volume":"40","author":"Hershko","year":"1978","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0450","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0955-3886(00)00087-4","article-title":"The importance of non-transferrin bound iron in disorders of iron metabolism","volume":"23","author":"Breuer","year":"2000","journal-title":"Transfus. Sci."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0455","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/j.lpm.2017.05.037","article-title":"Genetic hemochromatosis: pathophysiology, diagnostic and therapeutic management","volume":"46","author":"Brissot","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0460","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2005-02-0561","article-title":"Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin","volume":"106","author":"Drakesmith","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0465","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3324\/haematol.2017.170720","article-title":"Ferroportin disease: pathogenesis, diagnosis and treatment","volume":"102","author":"Pietrangelo","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0470","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/j.seminhematol.2005.01.002","article-title":"Management of anemia associated with myelodysplastic syndrome","volume":"42","author":"Hellstrom-Lindberg","year":"2005","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0475","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","author":"Murphy","year":"2010","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0480","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1016\/j.lpm.2017.10.014","article-title":"Iatrogenic iron overload and its potential consequences in patients on hemodialysis","volume":"46","author":"Rostoker","year":"2017","journal-title":"Presse Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0485","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.amjmed.2012.02.009","article-title":"Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation","volume":"125","author":"Vaziri","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0490","first-page":"S11","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","author":"KDOQI","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050295","article-title":"Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients","volume":"7","author":"Kuo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0500","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2014.114","article-title":"Association between hemoglobin variability, serum ferritin levels, and adverse events\/mortality in maintenance hemodialysis patients","volume":"86","author":"Kuragano","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0505","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2014.275","article-title":"Data from the dialysis outcomes and practice patterns study validate an association between high intravenous iron doses and mortality","volume":"87","author":"Bailie","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0510","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1681\/ASN.2014090922","article-title":"Considerations and challenges in defining optimal iron utilization in hemodialysis","volume":"26","author":"Charytan","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0515","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0609.2012.01783.x","article-title":"Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron","volume":"89","author":"Ghoti","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0520","first-page":"68","article-title":"Liver and cardiac Iron deposition in patients on maintenance hemodialysis by magnetic resonance imaging T2","volume":"10","author":"Tolouian","year":"2016","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0525","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/nep.12735","article-title":"Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis","volume":"22","author":"Holman","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0530","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1016\/S0021-9258(18)83758-9","article-title":"Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy","volume":"264","author":"Grootveld","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0535","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-0609.2012.01779.x","article-title":"T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice","volume":"88","author":"Kumfu","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0540","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1113\/EP085517","article-title":"Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice","volume":"101","author":"Kumfu","year":"2016","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0545","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1073\/pnas.0606424103","article-title":"Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells","volume":"103","author":"Liuzzi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0550","doi-asserted-by":"crossref","first-page":"34032","DOI":"10.1074\/jbc.M112.367284","article-title":"ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading","volume":"287","author":"Wang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0555","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cmet.2015.05.002","article-title":"SLC39A14 is required for the development of hepatocellular Iron overload in murine models of hereditary hemochromatosis","volume":"22","author":"Jenkitkasemwong","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0560","first-page":"551","article-title":"Ferritin: design and formation of an iron-storage molecule","volume":"304","author":"Ford","year":"1984","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0565","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0570","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0575","doi-asserted-by":"crossref","first-page":"H659","DOI":"10.1152\/ajpheart.00452.2017","article-title":"Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes","volume":"314","author":"Baba","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0580","doi-asserted-by":"crossref","first-page":"H772","DOI":"10.1152\/ajpheart.00692.2017","article-title":"Ferroptosis: beating on death's door","volume":"314","author":"Dhingra","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0585","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.29117","article-title":"Characterization of ferroptosis in murine models of hemochromatosis","volume":"66","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0590","doi-asserted-by":"crossref","first-page":"H978","DOI":"10.1152\/ajpheart.00597.2017","article-title":"TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease","volume":"314","author":"Zhabyeyev","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0595","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","article-title":"Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy","volume":"84","author":"Oudit","year":"2006","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0600","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1172\/JCI110787","article-title":"Hepatic lipid peroxidation in vivo in rats with chronic iron overload","volume":"71","author":"Bacon","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0605","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.CIR.100.6.675","article-title":"Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes. Implications for the arrhythmogenesis of human siderotic heart disease","volume":"100","author":"Kuryshev","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0610","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trsl.2006.05.005","article-title":"Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil","volume":"148","author":"Wood","year":"2006","journal-title":"Transl. Res."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0615","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1074248411407635","article-title":"Long-term efficacy of deferasirox in preventing cardiovascular complications in the iron-overloaded gerbil","volume":"17","author":"Al-Rousan","year":"2012","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0620","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcmd.2015.06.003","article-title":"Experimental animal model to study iron overload and iron chelation and review of other such models","volume":"55","author":"Italia","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0625","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI114934","article-title":"Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload","volume":"86","author":"Houglum","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0630","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00109-003-0508-x","article-title":"Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1\/ferroportin","volume":"82","author":"Herrmann","year":"2004","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0635","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1172\/JCI25049","article-title":"A mouse model of juvenile hemochromatosis","volume":"115","author":"Huang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0640","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2006-02-003376","article-title":"Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis","volume":"108","author":"Lesbordes-Brion","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0645","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1053\/j.gastro.2006.11.028","article-title":"Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload","volume":"132","author":"Wallace","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0650","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/hep.23198","article-title":"Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload","volume":"50","author":"Wallace","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0655","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1182\/blood-2014-01-550467","article-title":"Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype","volume":"123","author":"Zumerle","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0660","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3389\/fphys.2017.00804","article-title":"Pulmonary Iron homeostasis in Hepcidin knockout mice","volume":"8","author":"Deschemin","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0665","first-page":"904","article-title":"A mouse model of cardiomyopathy induced by mutations in the hemochromatosis HFE gene","volume":"33","author":"Djemai","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0670","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171302","article-title":"Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy","volume":"38","author":"Das","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0675","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trsl.2010.11.002","article-title":"Interdependence of cardiac iron and calcium in a murine model of iron overload","volume":"157","author":"Otto-Duessel","year":"2011","journal-title":"Transl. Res."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0680","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1536\/ihj.50.829","article-title":"A case of iron overload cardiomyopathy: beneficial effects of iron chelating agent and calcium channel blocker on left ventricular dysfunction","volume":"50","author":"Sugishita","year":"2009","journal-title":"Int. Heart J."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0685","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.amjmed.2013.05.002","article-title":"Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial","volume":"126","author":"Fernandes","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0690","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood-2016-06-721183","article-title":"A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major","volume":"128","author":"Fernandes","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0695","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0700","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.0000046488.52939.BF","article-title":"Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I study (evaluation of nifedipine and cerivastatin on recovery of coronary endothelial function)","volume":"107","author":"Investigators","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0705","doi-asserted-by":"crossref","first-page":"16L","DOI":"10.1016\/S0002-9149(99)00360-4","article-title":"Antioxidant properties of calcium antagonists related to membrane biophysical interactions","volume":"84","author":"Mason","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbadis.2018.08.030_bb0710","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1161\/01.CIR.0000124229.40424.80","article-title":"Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model","volume":"109","author":"Oudit","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2018.08.030_bb0715","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cmet.2007.11.016","article-title":"The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression","volume":"7","author":"Schmidt","year":"2008","journal-title":"Cell Metab."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918303235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918303235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:47:05Z","timestamp":1760417225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918303235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":143,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0925443918303235"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.08.030","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of iron metabolism in heart failure: From iron deficiency to iron overload","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}